Related Experiment Videos
Management of gastrointestinal lymphoma
American Journal of Clinical Oncology
|June 1, 1984
Summary
Primary gastrointestinal lymphoma prognosis varies by histology and stage. Early-stage disease (Stage I/II) shows excellent survival, with radiotherapy effective for Stage I.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Primary gastrointestinal lymphoma is a rare malignancy.
- Understanding prognostic factors is crucial for patient management.
Purpose of the Study:
- To analyze the clinical characteristics and outcomes of primary gastrointestinal lymphoma.
- To evaluate the prognostic significance of histology and staging.
Main Methods:
- Retrospective analysis of 65 patients with primary gastrointestinal lymphoma.
- Histological classification using Rappaport's system.
- Modified staging system by Blackledge et al.
Main Results:
- Stomach was the most common site (62%).
- Diffuse histiocytic type had the worst prognosis (13.8 months median survival).
- Stage I/II disease had excellent 5-year survival (87% and 67%), while Stage III/IV had poorer survival (40% and 13%).
- Radiotherapy alone was effective for Stage I disease without complications.
Conclusions:
- Histology and stage are significant prognostic indicators for gastrointestinal lymphoma.
- Early-stage disease is associated with favorable outcomes.
- Radiotherapy is a viable treatment option for Stage I gastrointestinal lymphoma.